UnitedHealth Group – 2026-01-28 - Decrease Confidence 8/10

UNH – Decrease in Days/Weeks

UnitedHealth reported a narrow EPS beat of $2.11 versus $2.10 expected, but revenue of $113.2B missed forecasts and 2026 guidance slashed to $439B—down 2% YoY and well below the $454.6B consensus. The stock has already dropped 19% post-earnings, reflecting broad market concern over Medicare Advantage headwinds and membership losses.

Why This Matters

The core financial signal—declining revenue guidance amid rising regulatory pressure on Medicare payments—overrides the marginal EPS beat, especially as the company faces a $6B revenue hit from CMS coding changes and is actively shrinking its footprint with 3M+ expected membership reductions. This contraction, combined with bearish options activity, indicates institutional skepticism that current margins can be sustained, making near-term recovery unlikely despite a low forward P/E.

Key Insights

• Revenue Guidance: 2026 outlook >$439B, a 2% YoY decline and $15.6B below consensus
• News Impact: CMS’s near-flat 2027 Medicare Advantage rates and V28 coding transition to reduce revenue by $6B in 2026
• Risk/Offset: Debt/Equity of 75.734 signals high leverage, limiting flexibility during earnings contraction

Practical Implications

• Bull Case: Analysts maintain Strong Buy rating with $400 average target, suggesting deep value at current levels could attract buyers
• Bear Case: Continued downward revisions and membership erosion may drive stock toward 52-week low, especially if RSI shows no oversold bounce
• Confidence: 8/10 – Earnings miss, guidance cut, and structural Medicare headwinds create strong near-term downside momentum

Prediction: decrease

Reference:

• https://www.cnbc.com/2026/01/27/unitedhealth-group-unh-earnings-q4-2025.html
• https://www.benzinga.com/insights/options/26/01/50158456/unitedhealth-group-unusual-options-activity-for-january-27
• https://finance.yahoo.com/news/unitedhealth-nyse-unh-posts-q4-111451762.html